ETON ETON PHARMACEUTICALS INC More: the full row for ETON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,852,070 shares; 2025Q1: 2,852,070 shares; 2025Q2: 2,860,000 shares; 2025Q3: 2,860,000 shares; 2025Q4: 2,860,000 shares; 2026Q1: 2,860,000 shares; 2026Q2: 2,860,000 shares; 2026Q3: 2,440,000 shares 2,440,000 $126M 14.15% -420,000 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 85,000 shares; 2025Q2: 186,418 shares; 2025Q3: 193,773 shares; 2025Q4: 200,000 shares; 2026Q1: 421,000 shares; 2026Q2: 855,000 shares; 2026Q3: 1,095,000 shares 1,095,000 $71.7M 8.07% +240,000 Timeline HROW HARROW INC More: the full row for HARROW INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,990,000 shares; 2025Q1: 3,955,000 shares; 2025Q2: 3,905,000 shares; 2025Q3: 3,905,000 shares; 2025Q4: 3,905,000 shares; 2026Q1: 2,832,230 shares; 2026Q2: 2,400,000 shares; 2026Q3: 2,105,000 shares 2,105,000 $64.8M 7.3% -295,000 Timeline LQDA LIQUIDIA CORPORATION More: the full row for LIQUIDIA CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,698,142 shares; 2025Q1: 2,260,000 shares; 2025Q2: 2,475,000 shares; 2025Q3: 2,615,000 shares; 2025Q4: 2,435,000 shares; 2026Q1: 2,545,000 shares; 2026Q2: 2,447,500 shares; 2026Q3: 2,110,000 shares 2,110,000 $63.8M 7.19% -337,500 Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 220,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 268,423 shares; 2026Q1: 1,430,000 shares; 2026Q2: 1,439,996 shares; 2026Q3: 1,439,996 shares 1,439,996 $58.5M 6.59% 0 Timeline SLGL SOL-GEL TECHNOLOGIES LTD More: the full row for SOL-GEL TECHNOLOGIES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 204,835 shares; 2025Q4: 453,739 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 555,000 shares 555,000 $41.2M 4.64% +55,000 Timeline MGTX MEIRAGTX HLDGS PLC More: the full row for MEIRAGTX HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 390,844 shares; 2026Q1: 2,123,259 shares; 2026Q2: 3,550,000 shares; 2026Q3: 3,600,000 shares 3,600,000 $39.6M 4.46% +50,000 Timeline TGTX TG THERAPEUTICS INC More: the full row for TG THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,260,000 shares; 2025Q1: 535,000 shares; 2025Q2: 535,000 shares; 2025Q3: 535,000 shares; 2025Q4: 535,000 shares; 2026Q1: 535,000 shares; 2026Q2: 535,000 shares; 2026Q3: 557,000 shares 557,000 $31.1M 3.5% +22,000 Timeline ACOG ALPHA COGNITION INC More: the full row for ALPHA COGNITION INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 115,142 shares; 2025Q4: 2,070,784 shares; 2026Q1: 2,561,950 shares; 2026Q2: 2,895,467 shares; 2026Q3: 3,303,904 shares 3,303,904 $29.7M 3.35% +408,437 2026-10-23, Form 4 : bought 14,973 shares on 2026-10-23 Timeline IMMX IMMIX BIOPHARMA INC More: the full row for IMMIX BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,345,000 shares; 2026Q3: 2,825,000 shares 2,825,000 $29.4M 3.31% +480,000 Timeline CBIO CRESCENT BIOPHARMA INC. More: the full row for CRESCENT BIOPHARMA INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,178,300 shares; 2026Q1: 1,312,615 shares; 2026Q2: 1,319,351 shares; 2026Q3: 1,645,984 shares 1,645,984 $24M 2.71% +326,633 Timeline VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,800,000 shares; 2026Q3: 2,753,333 shares 2,753,333 $22.2M 2.5% +953,333 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 105,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $20.5M 2.31% 0 Timeline REPL REPLIMUNE GROUP INC More: the full row for REPLIMUNE GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,384,993 shares; 2026Q3: 1,384,993 shares 1,384,993 $18.3M 2.07% 0 Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 25,000 shares; 2025Q1: 300,000 shares; 2025Q2: 562,120 shares; 2025Q3: 682,017 shares; 2025Q4: 695,000 shares; 2026Q1: 700,000 shares; 2026Q2: 700,000 shares; 2026Q3: 692,181 shares 692,181 $18M 2.03% -7,819 Timeline SMMT SUMMIT THERAPEUTICS INC More: the full row for SUMMIT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,051,901 shares 1,051,901 $17.8M 2% new Timeline RZLT REZOLUTE INC More: the full row for REZOLUTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 465,000 shares; 2025Q1: 465,000 shares; 2025Q2: 903,442 shares; 2025Q3: 903,442 shares; 2025Q4: 6,287,156 shares; 2026Q1: 6,300,000 shares; 2026Q2: 6,300,000 shares; 2026Q3: 4,087,045 shares 4,087,045 $16.9M 1.91% -2,212,955 Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 77,915 shares; 2026Q3: 1,190,000 shares 1,190,000 $15.9M 1.79% +1,112,085 Timeline PTGX PROTAGONIST THERAPEUTICS INC More: the full row for PROTAGONIST THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 105,000 shares; 2025Q1: 105,000 shares; 2025Q2: 105,000 shares; 2025Q3: 105,000 shares; 2025Q4: 105,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $14.1M 1.59% 0 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 745,000 shares; 2026Q3: 1,035,000 shares 1,035,000 $12.3M 1.39% +290,000 Timeline RYTM RHYTHM PHARMACEUTICALS INC More: the full row for RHYTHM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 490,000 shares; 2025Q2: 475,000 shares; 2025Q3: 461,700 shares; 2025Q4: 330,000 shares; 2026Q1: 123,000 shares; 2026Q2: 122,500 shares; 2026Q3: 122,500 shares 122,500 $11.7M 1.31% 0 Timeline QTTB Q32 BIO INC More: the full row for Q32 BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 213,363 shares; 2026Q1: 1,256,228 shares; 2026Q2: 931,000 shares; 2026Q3: 1,120,000 shares 1,120,000 $9.26M 1.04% +189,000 Timeline HRMY HARMONY BIOSCIENCES HLDGS IN More: the full row for HARMONY BIOSCIENCES HLDGS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 230,000 shares 230,000 $9.03M 1.02% new Timeline EDIT EDITAS MEDICINE INC More: the full row for EDITAS MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,926,997 shares; 2026Q2: 3,861,930 shares; 2026Q3: 3,486,452 shares 3,486,452 $8.96M 1.01% -375,478 Timeline ALMS ALUMIS INC More: the full row for ALUMIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 775,000 shares; 2025Q3: 665,000 shares; 2025Q4: 535,000 shares; 2026Q1: 550,000 shares; 2026Q2: 550,000 shares; 2026Q3: 1,001,900 shares 1,001,900 $7.4M 0.83% +451,900 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 480,000 shares; 2025Q1: 395,000 shares; 2025Q2: 490,000 shares; 2025Q3: 500,000 shares; 2025Q4: 500,000 shares; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 175,000 shares 175,000 $7.11M 0.8% -325,000 Timeline GRCE GRACE THERAPEUTICS INC More: the full row for GRACE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,798,167 shares 2,798,167 $6.02M 0.68% new 2026-11-18, Form 4 : bought 2,974 shares on 2026-11-18 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 315,171 shares 315,171 $5.93M 0.67% new Timeline GOSS GOSSAMER BIO INC More: the full row for GOSSAMER BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 426,989 shares 426,989 $5.06M 0.57% new Timeline ADCT ADC THERAPEUTICS SA More: the full row for ADC THERAPEUTICS SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 682,529 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 700,000 shares; 2026Q3: 4,070,819 shares 4,070,819 $4.97M 0.56% +3,370,819 Timeline JSPR JASPER THERAPEUTICS INC More: the full row for JASPER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 280,808 shares 280,808 $4.89M 0.55% new Timeline FDMT 4D MOLECULAR THERAPEUTICS IN More: the full row for 4D MOLECULAR THERAPEUTICS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 112,291 shares; 2026Q2: 334,437 shares; 2026Q3: 334,437 shares 334,437 $4.79M 0.54% 0 Timeline INBX INHIBRX BIOSCIENCES INC More: the full row for INHIBRX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,291 shares; 2026Q3: 45,500 shares 45,500 $4.55M 0.51% +25,209 Timeline CABA CABALETTA BIO INC More: the full row for CABALETTA BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 808,882 shares; 2025Q4: 900,000 shares; 2026Q1: 1,380,000 shares; 2026Q2: 3,863,800 shares; 2026Q3: 2,321,602 shares 2,321,602 $4.46M 0.5% -1,542,198 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,317,500 shares; 2025Q1: 795,000 shares; 2025Q2: 390,000 shares; 2025Q3: 390,000 shares; 2025Q4: 345,100 shares; 2026Q1: 345,100 shares; 2026Q2: 310,000 shares; 2026Q3: 310,000 shares 310,000 $4.44M 0.5% 0 Timeline VYGR VOYAGER THERAPEUTICS INC More: the full row for VOYAGER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,196,904 shares; 2026Q1: 1,150,000 shares; 2026Q2: 1,185,000 shares; 2026Q3: 1,630,000 shares 1,630,000 $4.37M 0.49% +445,000 Timeline ZNTL ZENTALIS PHARMACEUTICALS INC More: the full row for ZENTALIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,767,500 shares; 2025Q1: 1,985,000 shares; 2025Q2: 1,924,300 shares; 2025Q3: 316,550 shares; 2025Q4: 1,400,906 shares; 2026Q1: 1,412,656 shares; 2026Q2: 1,412,656 shares; 2026Q3: 1,412,656 shares 1,412,656 $3.91M 0.44% 0 Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,342,500 shares; 2025Q1: 1,595,000 shares; 2025Q2: 1,595,000 shares; 2025Q3: 1,595,000 shares; 2025Q4: 1,595,000 shares; 2026Q1: 600,000 shares; 2026Q2: 600,000 shares; 2026Q3: 506,436 shares 506,436 $3.88M 0.44% -93,564 Timeline RLMD RELMADA THERAPEUTICS INC More: the full row for RELMADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 935,000 shares; 2026Q1: 935,000 shares; 2026Q2: 935,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $3.77M 0.42% +65,000 Timeline ANNX ANNEXON INC More: the full row for ANNEXON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,600,000 shares; 2025Q4: 2,600,000 shares; 2026Q1: 2,331,761 shares; 2026Q2: 1,714,451 shares; 2026Q3: 875,000 shares 875,000 $3.7M 0.42% -839,451 Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,175,000 shares; 2025Q2: 1,220,000 shares; 2025Q3: 1,100,000 shares; 2025Q4: 1,120,000 shares; 2026Q1: 1,120,000 shares; 2026Q2: 1,125,000 shares; 2026Q3: 750,000 shares 750,000 $3.63M 0.41% -375,000 Timeline CDXS CODEXIS INC More: the full row for CODEXIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,840,000 shares; 2025Q1: 9,500,000 shares; 2025Q2: 12,600,000 shares; 2025Q3: 12,795,000 shares; 2025Q4: 6,789,738 shares; 2026Q1: 6,785,000 shares; 2026Q2: 6,785,000 shares; 2026Q3: 2,590,000 shares 2,590,000 $3.6M 0.41% -4,195,000 Timeline BLSM BLOSSOMHILL THERAPEUTICS INC More: the full row for BLOSSOMHILL THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 175,000 shares 175,000 $3.26M 0.37% new Timeline LYEL LYELL IMMUNOPHARMA INC More: the full row for LYELL IMMUNOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 79,097 shares; 2026Q2: 344,025 shares; 2026Q3: 291,353 shares 291,353 $2.85M 0.32% -52,672 Timeline RCKT ROCKET PHARMACEUTICALS INC More: the full row for ROCKET PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 955,000 shares; 2026Q1: 955,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $2.63M 0.3% 0 Timeline BDSX BIODESIX INC More: the full row for BIODESIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 238,047 shares; 2026Q2: 180,000 shares; 2026Q3: 87,000 shares 87,000 $2.6M 0.29% -93,000 Timeline BBOT BRIDGEBIO ONCOLOGY THERAPEUT More: the full row for BRIDGEBIO ONCOLOGY THERAPEUT Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 53,282 shares; 2026Q2: 700,000 shares; 2026Q3: 630,000 shares 630,000 $2.58M 0.29% -70,000 Timeline OKYO OKYO PHARMA LTD More: the full row for OKYO PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,204 shares; 2026Q3: 1,620,000 shares 1,620,000 $2.09M 0.24% +1,244,796 2026-11-16, 13G : 5,000,000 shares, 9.53% of the class, 13G filed 2026-11-20 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 427,608 shares; 2026Q1: 427,608 shares; 2026Q2: 145,000 shares; 2026Q3: 140,463 shares 140,463 $1.97M 0.22% -4,537 Timeline ENTA ENANTA PHARMACEUTICALS INC More: the full row for ENANTA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 75,000 shares; 2026Q1: 125,000 shares; 2026Q2: 125,000 shares; 2026Q3: 125,000 shares 125,000 $1.65M 0.19% 0 Timeline FBIO FORTRESS BIOTECH INC More: the full row for FORTRESS BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,090,000 shares; 2026Q1: 1,042,000 shares; 2026Q2: 890,000 shares; 2026Q3: 720,000 shares 720,000 $1.54M 0.17% -170,000 Timeline SNWV SANUWAVE HEALTH INC More: the full row for SANUWAVE HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 972,002 shares; 2025Q2: 980,000 shares; 2025Q3: 980,000 shares; 2025Q4: 981,267 shares; 2026Q1: 981,267 shares; 2026Q2: 306,140 shares; 2026Q3: 306,140 shares 306,140 $1.44M 0.16% 0 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 250,000 shares; 2025Q2: 239,319 shares; 2025Q3: 253,000 shares; 2025Q4: 260,000 shares; 2026Q1: 260,000 shares; 2026Q2: 260,000 shares; 2026Q3: 20,000 shares 20,000 $1.17M 0.13% -240,000 Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 75,755 shares 75,755 $1.04M 0.12% new Timeline DERM JOURNEY MED CORP More: the full row for JOURNEY MED CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 69,323 shares; 2025Q2: 95,000 shares; 2025Q3: 971,064 shares; 2025Q4: 975,000 shares; 2026Q1: 960,000 shares; 2026Q2: 350,000 shares; 2026Q3: 125,000 shares 125,000 $855K 0.1% -225,000 Timeline KRRO KORRO BIO INC More: the full row for KORRO BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 69,348 shares 69,348 $687K 0.08% new Timeline SION SIONNA THERAPEUTICS INC More: the full row for SIONNA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 70,000 shares 70,000 $368K 0.04% new Timeline ADGM ADAGIO MED HLDGS INC More: the full row for ADAGIO MED HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 110,571 shares; 2025Q1: 110,571 shares; 2025Q2: 110,571 shares; 2025Q3: 110,571 shares; 2025Q4: 18,444 shares; 2026Q1: 18,444 shares; 2026Q2: 18,444 shares; 2026Q3: 18,444 shares 18,444 $2.82K <0.01% 0 Timeline